Sage Therapeutics (SAGE)
(Delayed Data from NSDQ)
$13.94 USD
+0.84 (6.37%)
Updated May 3, 2024 04:00 PM ET
After-Market: $13.96 +0.02 (0.14%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.69 | 0.00% |
Earnings Summary
For their last quarter, Sage Therapeutics (SAGE) reported earnings of -$1.80 per share, missing the Zacks Consensus Estimate of -$1.63 per share. This reflects a negative earnings surprise of 10.43%. Look out for SAGE's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.69 per share, reflecting a year-over-year increase of 36.94%.
Earnings History
Price & Consensus
Zacks News for SAGE
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
SAGE: What are Zacks experts saying now?
Zacks Private Portfolio Services